[Therapy of combined vaginal infections with Trichomonas vaginalis and Blastomycetes. A controlled double-blind comparison of Metronidazole and Clotrimazole].
D000284:Administration, Oral; D000287:Administration, Topical; D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008795:Metronidazole / Q000627:therapeutic use*; D010919:Placebos; D011247:Pregnancy; D014247:Trichomonas Vaginitis / Q000150:complications / Q000188:drug therapy*
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles; D010919:Placebos; D008795:Metronidazole
Therapie kombinierter Vaginalinfektionen von Trichomonas vaginalis und Sprosspilzen. Ein kontrollierter Doppelblindvergleich von Metronidazol und Clotrimazol